STOCK TITAN

Zhibao Technology (ZBAO) Stock Price, News & Analysis

ZBAO NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
116 252 sessions, November 5, 2025 to November 5, 2026
Largest daily move
+53.9% close of March 2, 2026
1-year change
-99.5% closing prices, November 5, 2025 to November 5, 2026
1-month change
-94.9% closing prices, October 5, 2026 to November 5, 2026

Company Description

Zhibao Technology Inc. (NASDAQ: ZBAO) is an InsurTech company in the financial services sector that focuses on digital insurance brokerage services in China. Through its operating entities, referred to as the Zhibao China Group, the company applies technology, data and platform-based tools to the insurance brokerage value chain. Zhibao describes its business as centered on a 2B2C (to-business-to-customer) digital embedded insurance model, which it states it pioneered in China, and it classifies itself as a high-growth provider of digital brokerage services.

The company’s core model is to embed insurance into existing business ecosystems. Zhibao China Group launched what it describes as the first digital insurance brokerage platform in China in 2020, built on a proprietary PaaS (Platform as a Service) architecture. According to the company, this platform supports the design, distribution and servicing of digital insurance products that are integrated into partner business channels and delivered to end customers.

Business model and operations

Zhibao states that its primary business is digital insurance brokerage, supported by a 2B2C digital embedded insurance framework. The company works with what it calls B channels (business channels), which include various business platforms and partners across different industries. Through these B channels, Zhibao offers embedded insurance products to C-end customers (end users). The company reports that these B channels are distributed across diverse market segments and are a key component of scaling its embedded model.

In its description, Zhibao notes that it has developed over 40 proprietary digital insurance solutions that address different scenarios in multiple industries, including travel, sports, logistics, utilities and e-commerce. These solutions are delivered and managed through its digital brokerage platform. Zhibao indicates that it acquires and analyzes customer data and uses big data and AI technology to iterate and enhance its digital insurance solutions, with the goal of aligning products with evolving customer preferences.

Beyond brokerage, Zhibao also provides Managing General Underwriter (MGU) services to insurance companies. According to the company, these MGU services can include product design, underwriting, reinsurance, claims and risk control within specific product or market segments. The MGU function is described as one of the core parts of its business model, and the company has stated that its existing MGU team and business are being integrated into certain joint venture structures focused on health and medical insurance.

Digital embedded insurance and B/C channel reach

The 2B2C embedded model is central to how Zhibao characterizes its operations. The company reports that it works with a large number of B channels and that these channels span various industries and sectors. Through these channels, Zhibao states that it has reached and served tens of millions of end customer users. Management commentary in its public communications links revenue growth to the expansion of B channels and the acceptance of its 2B2C model, as well as to demand for its digital brokerage platform and insurance solutions.

According to the company’s own descriptions, Zhibao’s embedded approach allows insurance products to be integrated into existing business platforms, where end customers can access coverage in the context of other services. Zhibao frames this as a way to grow its digital brokerage revenues and to diversify its revenue base within the insurance value chain.

Technology platform and data use

Zhibao emphasizes that its brokerage platform is powered by a proprietary PaaS and that it relies on big data and AI to support product development and refinement. The company states that it acquires and analyzes customer data and uses this information to continually adjust and improve its digital insurance solutions. This iterative process is described as helping the company stay aligned with new trends and customer preferences in the Chinese insurance market.

The company also highlights its use of technology in risk management and product design, particularly within its MGU and health-related initiatives. In public materials, Zhibao links its technology capabilities to its ability to support embedded insurance offerings across multiple industries and to manage complex product structures, including those in the medical insurance space.

Reinsurance and Zhibao Labuan

Zhibao has established a wholly owned subsidiary, Zhibao Labuan Reinsurance Company Limited (Zhibao Labuan), incorporated in Malaysia. According to company disclosures, Zhibao Labuan was founded in April 2025 and received a general reinsurance license from the Labuan Financial Services Authority (LFSA) in July 2025. The company has also reported that Zhibao Labuan received a Financial Strength Rating of B+ (Good) and a Long-Term Issuer Credit Rating of "bbb-" (Good) from AM Best, with a stable outlook.

In its own description, Zhibao states that Zhibao Labuan was created to reinsure a share of business produced by the company’s operating entities in China, including Sunshine Insurance Brokers and Zhibao Health. The company also notes that this reinsurance subsidiary is intended to enable it to access an additional revenue stream through reinsurance premiums and potential underwriting profits related to reinsured policies. Zhibao has indicated that Zhibao Labuan operates alongside its digital embedded brokerage, MGU and risk management units, and that the parent company remains primarily an insurance brokerage business.

Health and medical insurance initiatives

Zhibao has disclosed several initiatives related to health and medical insurance. Through its wholly owned subsidiary Zhibao Health, the company announced the launch of the "Ren Ren Kang Yue" medical insurance product in collaboration with the People’s Insurance Company of China (PICC). This product is described as a middle-market medical insurance offering designed for urban residents within a defined age range in China, with features such as direct billing and access to specific types of hospital wards and selected private providers, positioned at price points intended to be accessible to young professionals and families. The product is distributed through PICC’s nationwide sales network, Zhibao’s subsidiary Sunshine Insurance Brokers, and additional third-party channels and platforms.

The company has also formed a joint venture, Shanghai Zhibao Yingshi Health Technology Co. Ltd (Zhibao Yingshi), with a partner active in the mid-end medical insurance space in China. Under the relevant cooperation framework agreement, Zhibao’s Chinese operating entity agreed to hold a majority equity interest in Zhibao Yingshi. Zhibao has stated that it will contribute its strengths and resources to this joint venture by providing reinsurance, brokerage, medical network and risk management services, and that its existing MGU team and business will be merged into the joint venture.

Strategic partnerships and joint ventures

In addition to its health-related ventures, Zhibao has described other collaborative initiatives. The company has signed an agreement to collaborate on establishing a joint venture company referred to as Zhongfang JV with Beijing Zhongfang Hongchuang Technology Company Limited, a wholly owned subsidiary of the China Disaster Prevention Association, and Guangzhou Ruiling Intelligent Technology Co. Ltd. According to Zhibao, the purpose of this joint venture is to develop an "Insurance + Technology + Service" model and deepen cooperation in the field of risk reduction services across China.

Zhibao has also reported that its subsidiary, Zhibao China, agreed to acquire a 51% equity interest in Zhonglian Jinan Insurance Brokers Co., Ltd. (Zhonglian) pursuant to a share purchase agreement, and that this equity ownership was acquired, subject to installment arrangements and potential adjustments. The company links such acquisitions and partnerships to its efforts to diversify its revenue base, expand its B channels and strengthen its presence in various insurance segments.

Capital markets and financing arrangements

Zhibao Technology Inc. is a Cayman Islands exempted company whose Class A ordinary shares trade on Nasdaq under the symbol ZBAO. The company has disclosed that it entered into an Equity Purchase Agreement with Hudson Global Ventures, LLC to establish an equity line of credit facility. Under this arrangement, Hudson agreed to purchase up to a specified aggregate limit of the company’s Class A ordinary shares over a defined commitment period, subject to conditions and pricing formulas based on market prices and trading volumes. The company also entered into a related Registration Rights Agreement and a Financing Consulting Agreement with a consultant, under which it agreed to issue shares and pay a percentage of cash proceeds from certain financings.

These financing structures, as described in the company’s filings, are intended to provide access to capital through periodic issuances of Class A ordinary shares, subject to regulatory and contractual conditions. The company has also addressed material weaknesses in internal control over financial reporting in its registration statements and annual report, noting areas such as personnel with U.S. GAAP expertise and IT logical access security.

Regulatory and listing considerations

Zhibao has reported that it received a Nasdaq deficiency notice related to a delay in filing its annual report on Form 20-F for a specified fiscal year. According to the company, this notice indicated non-compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports. Zhibao has stated that the notice did not have an immediate effect on the listing of its Class A ordinary shares and that the shares continued to trade under the symbol ZBAO. The company has also outlined the timelines and process for submitting a plan to regain compliance and the potential for an exception period.

In its communications, Zhibao has indicated that it is working to complete its required filings and has referenced earnings calls and investor webinars where management discusses financial and operational performance, guidance and strategic plans. The company has also disclosed changes in its independent registered public accounting firm and described the engagement of a new auditor, including prior work by that auditor with an acquired insurance brokerage entity.

Management, governance and subsidiaries

Public filings and press releases describe several key roles within Zhibao’s leadership and its operating structure. The company references executives responsible for operations, marketing and actuarial functions, and notes that some of these individuals previously held roles within its Chinese operating entities. Zhibao’s filings describe employment agreements for certain executives at subsidiaries such as Sunshine Insurance Broker (Shanghai) Co., Ltd. and Zhibao Technology Co., Ltd. (Zhibao China), including terms related to base salary, bonuses, benefit participation, and restrictive covenants on non-competition, non-solicitation and confidentiality.

The company’s structure includes multiple subsidiaries and affiliated entities, such as Sunshine Insurance Brokers, Zhibao Health, Zhibao Labuan and majority-owned or joint venture companies like Zhonglian and Zhibao Yingshi. These entities are referenced in connection with brokerage operations, health insurance product development, reinsurance activities and channel expansion.

Industry focus and market positioning

Zhibao operates within the insurance brokers industry and the broader financial services sector, with a stated emphasis on InsurTech. The company positions itself as a high-growth digital insurance brokerage business that integrates technology, data analytics and platform-based distribution. Its public statements highlight its focus on embedded insurance, digital platforms, MGU capabilities, reinsurance through Zhibao Labuan, and health and medical insurance collaborations.

According to its own descriptions, Zhibao’s role in the insurance ecosystem spans brokerage, product design, risk management and reinsurance for specific segments. The company links its growth to the expansion of B channels, increased acceptance of its 2B2C model, strategic partnerships, mergers and acquisitions, and investments in its sales force and technology platform.

Stock Performance

$0.2265
-0.22%
-0.0005
After hoursChange vs the $0.2270 closeLast updated: November 5, 2026 at 19:03
-99.5%
Performance 1 year

Zhibao Technology (ZBAO) closed at $0.2270 on November 5, 2026. Over the past 12 months, the price has lost 99.5%.

See what a $1,000 investment in ZBAO would be worth today

Average down calculator for ZBAO

ZBAO Metrics & Rankings

Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Zhibao Technology has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include crypto, partnership, stock split, acquisition, AI. View all ZBAO news →

Financial Highlights

Zhibao Technology generated $38.7M in revenue in FY2025, retaining a 41.0% gross margin, operating income reached -$7.5M (-19.3% operating margin), and net income was -$8.7M, reflecting a -22.4% net profit margin. Diluted earnings per share stood at -$0.27. The company generated -$2.9M in operating cash flow. The current ratio was 1.00, measuring current assets divided by current liabilities.

$38.7M
Revenue (FY2025)
-$8.7M
Net Income (FY2025)
-$2.9M
Operating Cash Flow

Upcoming Events

YEAR
2027
2027 Corporate

ROFR deadline

Deadline to exercise right of first refusal for additional 34% equity stake
JAN
06
January 6, 2027 Regulatory

Nasdaq compliance deadline

Deadline to regain Nasdaq minimum $1.00 bid for 10 consecutive business days; failure risks delisting; notice issued by Nasdaq.
JUL
05
July 5, 2027 Regulatory

Nasdaq extension deadline

Potential additional 180-day Nasdaq compliance period ending 2027-07-05 if extension is granted; contingent on Nasdaq approval.

Zhibao Technology has 3 upcoming scheduled events. The next event, "ROFR deadline", is expected in 2027. Investors can track these dates to stay informed about potential catalysts that may affect the ZBAO stock price.

Short Interest History

Last 12 Months

Short interest in Zhibao Technology (ZBAO) currently stands at 115.9 thousand shares, representing 1.3% of the float. A stock split fell inside this reporting period, so the figure cannot be compared with the previous one.

Days to Cover History

Last 12 Months

Days to cover for Zhibao Technology (ZBAO) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 23.1%. Across the settlements charted above, it has ranged from 1.0 to 2.6 days.

ZBAO Company Profile & Sector Positioning

Zhibao Technology (ZBAO) operates in the Insurance Brokers industry within the broader Financial Services sector and is listed on the NASDAQ.

Investors comparing ZBAO often look at related companies in the same sector, including eHealth, Inc. (EHTH), Reliance Global Group, Inc. (EZRA), Huize Holding Limited (HUIZ), AIFU Inc. (AIFU), and XChange TEC.INC (XHG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ZBAO's relative position within its industry.

Frequently Asked Questions

The current stock price of Zhibao Technology (ZBAO) is $0.2265 in after-hours trading as of November 5, 2026.

The market cap of Zhibao Technology (ZBAO) is approximately $5.8M. Learn more about what market capitalization means .

The FY2025 revenue of Zhibao Technology (ZBAO) is $38.7M, from its most recent completed fiscal year.

The FY2025 net income of Zhibao Technology (ZBAO) is -$8.7M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Zhibao Technology (ZBAO) is -$0.27 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Zhibao Technology (ZBAO) is -$2.9M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Zhibao Technology (ZBAO) is -22.4% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Zhibao Technology (ZBAO) is -19.3% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Zhibao Technology (ZBAO) is 41.0% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Zhibao Technology (ZBAO), current assets divided by current liabilities, was 1.00 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Zhibao Technology (ZBAO) is $15.9M for FY2025, its most recent completed fiscal year.

The operating income of Zhibao Technology (ZBAO) is -$7.5M for FY2025, its most recent completed fiscal year. Learn about operating income.

Zhibao Technology Inc.’s core business is providing digital insurance brokerage services through its operating entities in China. The company focuses on a 2B2C digital embedded insurance model, embedding insurance products into partner business platforms and delivering them to end customers.

In Zhibao’s 2B2C model, the company works with B channels—business partners across various industries—to embed insurance products into their platforms. These embedded products are then accessed by C-end customers, allowing Zhibao to distribute digital insurance through existing business ecosystems.

According to the company, Zhibao has developed over 40 proprietary digital insurance solutions addressing scenarios in industries such as travel, sports, logistics, utilities and e-commerce. These solutions are delivered through its digital insurance brokerage platform.

Zhibao states that its digital insurance brokerage platform is powered by a proprietary Platform as a Service (PaaS). The company reports that it acquires and analyzes customer data and uses big data and AI technology to iterate and enhance its digital insurance solutions.

Zhibao provides Managing General Underwriter services to insurance companies. The company indicates that these services can include product design, underwriting, reinsurance, claims and risk control within specific product or market segments, forming a core part of its business model.

Zhibao Labuan Reinsurance Company Limited is a wholly owned subsidiary of Zhibao Technology, incorporated in Malaysia. It was founded in April 2025 and received a general reinsurance license in July 2025. Zhibao states that Zhibao Labuan reinsures a share of business produced by its operating entities and provides an additional revenue stream through reinsurance premiums and potential underwriting profits.

Zhibao, through its subsidiary Zhibao Health, launched the "Ren Ren Kang Yue" middle-market medical insurance product in collaboration with the People’s Insurance Company of China (PICC). The company has also formed the Zhibao Yingshi joint venture, where it contributes reinsurance, brokerage, medical network and risk management services and merges its existing MGU team into the venture.

Zhongfang JV is a joint venture that Zhibao agreed to establish with Beijing Zhongfang Hongchuang Technology Company Limited, a wholly owned subsidiary of the China Disaster Prevention Association, and Guangzhou Ruiling Intelligent Technology Co. Ltd. Zhibao states that this joint venture aims to develop an "Insurance + Technology + Service" model to deepen cooperation in risk reduction services across China.

Zhibao Technology Inc.’s Class A ordinary shares trade on The Nasdaq Stock Market under the ticker symbol ZBAO, as stated in the company’s press releases and SEC filings.

Yes. Zhibao has disclosed that it received a Nasdaq deficiency notice because it had not filed its annual report on Form 20-F for a specified fiscal year by the required date. The company reported that the notice did not immediately affect the listing of its Class A ordinary shares and that it has a defined period to submit a plan to regain compliance.

Zhibao entered into an Equity Purchase Agreement with Hudson Global Ventures, LLC, under which Hudson agreed to purchase up to a specified aggregate limit of the company’s Class A ordinary shares over a two-year commitment period. The company also signed a Registration Rights Agreement related to the resale of these shares and a Financing Consulting Agreement that provides for the issuance of consulting shares and a percentage of cash proceeds from such financings.

Zhibao has disclosed that its subsidiary, Zhibao China, entered into a share purchase agreement to acquire a 51% equity interest in Zhonglian Jinan Insurance Brokers Co., Ltd. The company reports that this majority ownership was acquired, subject to installment payments and potential adjustments, as part of its strategy to expand its insurance brokerage operations.